Features of formation of the fetoplacental complex following transfer of fresh and vitrified embryos in in vitro fertilization programs


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The paper gives an update on the relationship between genetically determined hemostasiological disorders and the expression level of proangiogenic factors in the formation of the fetoplacental complex and analyzes obstetric and perinatal outcomes following transfer of fresh and vitrified embryos in in vitro fertilization programs based on the data available in the Russian and foreign scientific literature. It shows the role of hemostasiological and proangiogenic factors in the formation of the fetoplacental complex and analyzes obstetric and perinatal outcomes after transfer of fresh and vitrified embryos in in vitro fertilization programs. The authors describe the role of vascular endothelial growth factor and the vascular anticoagulant annexin V in the formation of the placental vascular network that is of particular interest in using the methods of assisted reproductive medicine as the major organ that ensures fetal formation and growth. Further studies will help identify genetic and phenotypic risk factors for placental insufficiency following transfer of fresh and vitrified embryos in in vitro fertilization programs during both hormone replacement therapy and a natural cycle, which will be able to assess perinatal outcomes and to contribute to their improvement.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Victoria Shumovskaya

Ural Research Institute of Maternal and Infant Care, Ministry of Health of Russia

Email: shumvictory@mail.ru
obstetrician gynecologist, post-graduate student

Natalia Putilova

Ural Research Institute of Maternal and Infant Care, Ministry of Health of Russia

Email: putilova-1959@mail.ru
MD, Associate Professor, Head of antenatal protection of the fetus

Dmitrii Mazurov

Ural Research Institute of Maternal and Infant Care, Ministry of Health of Russia

Email: dmazurov@mail.ru
PhD, obstetrician gynecologist, head of the department

Әдебиет тізімі

  1. Петров Ю.А., Байкулова Т.Ю. Клинические особенности течения беременности, родов и послеродового периода у первородящих повторнобеременных женщин. Международный журнал прикладных и фундаментальных исследований. 2016; 8(5): 719-23.
  2. Li J., Chen Y., Liu C., Hu Y., Li L. Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta-analysis. Am. J. Reprod. Immunol. 2013; 70(6): 434-47.
  3. Kushnir V.A., Vidali A., Barad D.H., Gleicher N. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertil. Steril. 2013; 100(3): 736-41.
  4. Kushnir V.A., Darmon S.K., Barad D.H., Gleicher N. New national outcome data on fresh versus cryopreserved donor oocytes. J. Ovarian Res. 2018; 11(1): 2.
  5. Centers for Disease Control and Prevention (CDC), American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2011 Assisted Reproductive Technology: National Summary Report. Atlanta: US Department of Health and Human Services; 2013.
  6. Lee G.H., Song H.J., Lee K.S., Choi Y.M. Current status of assisted reproductive technology in Korea. Clin. Exp. Reprod. Med. 2015; 42(1): 8-13.
  7. Корсак В.С. Отчет регистра ВРТ за 2015 год. В. кн.: Материалы XXVII международной конференции „Репродуктивные технологии сегодня и завтра”. Санкт-Петербург, 6-9 сентября 2017 г. СПб.: 2017.
  8. Радзинский В.Е., Гагаев Ч.Г. Патология пуповины. М.: ГЭОТАР-Медиа; 2011. 95с.
  9. Lee M.S., Cantonwine D., Little S.E., McElrath T.F., Parry S.I., Lim K.H., Wilkins-Haug L.E. Angiogenic markers in pregnancies conceived through in vitro fertilization. Am. J. Obstet. Gynecol. 2015; 213(2): 212. e1-8.
  10. Aplin J.D. Developmental cell biology of human villous trophoblast: current research problems. Int. J. Dev. Biol. 2010; 54(2-3): 323-9.
  11. Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int. J. Dev. Biol. 2010; 54(2-3): 269-80.
  12. Hoeller A., Ehrlich L., Golic M., Herse F., Siwetz M., Henrich W. et al. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies. Hypertens. Pregnancy. 2017; 36(2): 151-60.
  13. Shapiro B.S., Daneshmand S.T., Garner F.C., Aguirre M., Hudson C., Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil. Steril. 2011; 96(2): 344-8.
  14. Zollner U., Specketer M.T., Dietl J., Zollner K.P. 3D-Endometrial volume and outcome of cryopreserved embryo replacement cycles. Arch. Gynecol. Obstet. 2012; 286(2): 517-23.
  15. Fritz R., Jain C., Armant D.R. Cell signaling in trophoblast-uterine communication. Int. J. Dev. Biol. 2014; 58(2-4): 261-71.
  16. Brandes M., Hamilton C.J., van der Steen J.O., de Bruin J.P., Bots R.S., Nelen W.L., Kremer J.A. Unexplained infertility: overall ongoing pregnancy rate and mode of conception. Hum. Reprod. 2011; 26(2): 360-8.
  17. Alansari L., Akande V. How to maximize the pregnancy rate with no increase in multiple pregnancy rates following blastocyst embryo transfer? Is blastocyst transfer time the missing ingredient? Middle East Fertil. Soc. J. 2015; 20(4): 241-5.
  18. Kamel H., Navi B.B., Sriram N., Hovsepian D.A., Devereux R.B., Elkind M.S. Risk of a thrombotic event after the 6-week postpartum period. N. Engl. J. Med. 2014; 370(14): 1307-15.
  19. McLean K.C., Bernstein I.M., Brummel-Ziedins K.E. Tissue factor-dependent thrombin generation across pregnancy. Am. J. Obstet. Gynecol. 2012; 207(2): 135. e1-6.
  20. Иванец Т.Ю., Виноградова М.А., Долгушина Н.В. Референсные интервалы для гемостазиологических лабораторных тестов в динамике физиологической беременности. Акушерство и гинекология. 2016; 9: 50-9. [Ivanets T.Yu., Vinogradova M.A., Dolgushina N.V. Reference intervals for hemostasiological laboratory tests during physiological pregnancy. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2016; (9): 50-9. (in Russian)] http:// dx.doi.org/10.18565/aig.2016.9.50-9
  21. Макацария А.Д., Акиньшина С.В., Бицадзе В.О. Прэклампсия и HELLP-синдром как проявление тромботической микроангиопатии. Акушерство и гинекология. 2014; 4: 4-10.
  22. Rodger M.A., Betancourt M.T., Clark P., Lindqvist P.G., Dizon-Townson D., Said J. et al. The association of factor. V. Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: A systematic review and metaanalysis of prospective cohort studies. PLoS Med. 2010; 7(6): e1000292.
  23. Rova K., Passmark H., Lindqvist P.G. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil. Steril. 2012; 97(1): 95-100.
  24. Ndukwe G. Recurrent embryo implantation failure after in vitro fertilisation: improved outcome following intralipid infusion in women with elevated T. Helper 1 response. Hum. Fertil. (Camb.). 2011; 14920: 131-46.
  25. Rodger M.A., Carrier M., Le Gai G., Martinelli I., Perna A., Rey E. et al.; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood. 2014; 123(6): 822-8.
  26. Farhang Ghahremani M., Goossens S., Haigh J.J. The p53 family and VEGF regulation: “it’s complicated”. Cell Cycle. 2013; 12(9): 1331-2.
  27. Чепанов С.В., Шляхтенко Т.Н., Зайнулина М.С., Мирашвили М.И., Соколов Д.И., Сельков С.А. Антитела к аннексину V. у женщин с привычным невынашиванием беременности. Акушерство и гинекология. 2014; 7: 29-32.
  28. Тамразян А.А., Макаров О.В., Керчелаева С.Б., Бурденко М.В. Прогностическая значимость антител к аннексину-5 в развитии осложнений беременности и родов. Вестник РУДН. Серия: Медицина. 2011; 6: 366-72.
  29. Eum J.H., Park J.K., Kim S.Y., Paek S.K., Seok H.H., Chang E.M. et al. Clinical outcomes of single versus double blastocyst transfer in fresh and vitrified-warmed cycles. Clin. Exp. Reprod. Med. 2016; 43(3): 164-8.
  30. Sunderam S., Kissin D.M., Crawford S.B., Folger S.G., Jamieson D.J., Warner L., Barfield W.D. Assisted reproductive technology surveillance - United States, 2014. MMWR Surveill. Summ. 2017; 66(6): 1-24.
  31. Aleixandre-Benavent R., Simon C., Fauser B.C.JM. Trends in clinical reproductive medicine research: 10 years of growth. Fertil. Steril. 2015; 104(1): 131-7.
  32. Check J.H., Wilson C., Choe J.K., Amui J., Brasile D. Evidence that high serum progesterone (P) levels on day of human chorionic gonadotropin (hCG) injection have no adverse effect on the embryo itself as determined by pregnancy outcome following embryo transfer using donated eggs. Clin. Exp. Obstet. Gynecol. 2010; 37(3): 179-80.
  33. Павлова Т.В., Петрухин В.А., Струкова С.А. Особенности течения беременности и родов при экстракорпоральном оплодотворении с одноплодной беременностью. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. 2011; 4: 185-8.
  34. Максимова В.О. Современное состояние проблемы здоровья детей, рожденных в результате вспомогательных репродуктивных технологий. Педиатрическая фармакология. 2011; 8(2): 27-31.
  35. Pinborg A., Loft A., Aaris Henningsen A.K., Rasmussen S., Andersen A.N. Infant outcome of 957 singletons born after frozen embryoreplacement: The Danish National Cohort Study 1995-2006. Fertil. Steril. 2010; 94(4): 1320-7. Уточн. нумерацию.
  36. Pelkonen S., Hartikainen A.L., Ritvanen A., Koivunen R., Martikainen H., Gissler M. et al. Major congenital anomalies in children born after frozen embryo transfer: a cohort study 1995-2006. Hum. Reprod. 2014; 29: 1552-7.
  37. Gibreel A., Badawy A., El-Refai W., El-Adawi N. Endometrial scratching to improve pregnancy rate in couples with unexplained subfertility: a randomized controlled trial. J. Obstet. Gynaecol. Res. 2013; 39(3): 680-4.
  38. Greer I.A., Brenner B., Gris J.C. Antithrombotic treatment for pregnancy complications: Which path for the journey to precision medicine? Br. J. Haematol. 2014; 165(5): 585-99.
  39. Shi W., Xue X., Zhang S., Zhao W., Liu S., Zhou H. et al. Perinatal and neonatal outcomes of 494 babies delivered from 972 vitrified embryo transfers. Fertil. Steril. 2012; 97(6): 1338-42.
  40. Chambers G.M., Ledger W. The economic implications of multiple pregnancy following ART. Semin. Fetal Neonatal Med. 2014; 19(4): 254-61.
  41. Lemos E.V., Zhang D., Van Voorhis B.J., Hu X.H. Healthcare expenses associated with multiple vs singleton pregnancies in the United States. Am. J. Obstet. Gynecol. 2013; 209(6): 586. e1-586. e11.
  42. Li H.Z., Qiao J., Chi H.B., Chen X.N., Liu P., Ma C.H. Comparison of the major malformation rate of children conceived from cryopreserved embryos and fresh embryos. Chin. Med. J. (Engl.). 2010; 123(14): 1893-7.
  43. Maheshwari A., Griffiths S., Bhattacharya S. Global variations in the uptake of single embryo transfer. Hum. Reprod. Update. 2011; 17(1): 107-20.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>